BiomX appoints new director following board resignations Feb 13, 2026 04:09PM
BiomX addresses unusual stock trading activity Jan 27, 2026 01:49PM
H.C. Wainwright Reiterates Buy Rating on BiomX (PHGE) Nov 28, 2025 06:37AM
BiomX Inc. (PHGE) Tops Q3 EPS by 29c Nov 12, 2025 04:22PM
H.C. Wainwright Reiterates Buy Rating on BiomX (PHGE) Aug 20, 2025 06:40AM


Aug 19, 2025 08:20AM FDA places clinical hold on BiomX cystic fibrosis drug trial
Aug 13, 2025 08:15AM BiomX Inc. (PHGE) Misses Q2 EPS by 19c
Jul 15, 2025 07:16AM H.C. Wainwright Reiterates Buy Rating on BiomX (PHGE)
Jul 15, 2025 06:13AM H.C. Wainwright Reiterates Buy Rating on BiomX (PHGE)
Jul 14, 2025 09:01AM BiomX doses first patient in Phase 2b cystic fibrosis trial
May 16, 2025 06:45AM BiomX (PHGE) PT Lowered to $15 at H.C. Wainwright
May 15, 2025 04:50PM BiomX Inc. (PHGE) Misses Q1 EPS by 33c
Apr 4, 2025 06:44AM H.C. Wainwright Reiterates Buy Rating on BiomX (PHGE)
Apr 1, 2025 06:47AM BiomX (PHGE) PT Raised to $21 at H.C. Wainwright
Mar 31, 2025 06:31AM BiomX Inc. (PHGE) Announces Positive Topline Results from Phase 2 Trial of BX211
Nov 15, 2024 07:28AM H.C. Wainwright Reiterates Buy Rating on BiomX (PHGE)
Aug 16, 2024 02:58PM H.C. Wainwright Reiterates Buy Rating on BiomX (PHGE)
Aug 15, 2024 06:32AM BiomX Inc. (PHGE) Tops Q2 EPS by 16c
Jul 10, 2024 06:31AM BiomX Inc. (PHGE) Announces Stockholder Approval for Conversion of Outstanding Series X Convertible Preferred Stock to Common Stock